Burnham Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$235K Sell
7,220
-4,062
-36% -$124K 0.07% 181
2016
Q1
$330K Sell
11,282
-576
-5% -$15.3K 0.1% 166
2015
Q4
$396K Buy
11,858
+100
+0.9% +$3.11K 0.11% 162
2015
Q3
$334K Sell
11,758
-350
-3% -$12.2K 0.09% 177
2015
Q2
$490K Sell
12,108
-20
-0.2% -$898 0.11% 156
2015
Q1
$597K Sell
12,128
-74
-0.6% -$3.43K 0.14% 151
2014
Q4
$555K Buy
+12,202
New +$479K 0.13% 153

Other funds holding AVNS

Burnham Asset Management's AVNS Position: Q2 2016 in Review

Burnham Asset Management reduced its Avanos Medical (AVNS) stake by 36% in Q2 2016, selling an estimated $124K and leaving 7,220 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #181.

Burnham Asset Management first reported a position in AVNS in Q4 2014 and has held it in 7 quarters since. The position peaked at $597K in Q1 2015. 351 funds tracked by Wall St. Rank hold AVNS as of Q2 2016.

  • Burnham Asset Management held 7,220 shares of Avanos Medical worth $235K as of Q2 2016.
  • Burnham Asset Management sold 4,062 Avanos Medical shares in Q2 2016, an estimated $124K.
  • Avanos Medical made up 0.07% of Burnham Asset Management's portfolio in Q2 2016, its #181 holding.
  • Burnham Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 7 quarters since.
  • Burnham Asset Management's Avanos Medical position peaked at $597K in Q1 2015.
  • 351 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.